Traitement clinique de la drépanocytose par édition de base de haute précision — le CS-101 de CorrectSequence Therapeutics obtient des résultats prometteurs chez la première patiente
SHANGHAI, 29 août 2025 /PRNewswire/ — CorrectSequence Therapeutics Co., Ltd. (Correctseq), une société de biotechnologie au stade clinique, pionnière de la transformer Base Editing (tBE) pour le traitement de maladies graves, a récemment annoncé la réussite du traitement de la première patiente atteinte de drépanocytose grâce à sa thérapie par édition de base de haute précision, le […]
Tetragon Financial Group Limited July 2025 Monthly Factsheet
LONDON, Aug. 29, 2025 /PRNewswire/ — Tetragon has released its Monthly Factsheet for July 2025. Net Asset Value: $3,521m Fully Diluted NAV per Share: $38.41 Share Price (TFG NA): $16.80 Monthly NAV per Share Total Return: -0.6% Monthly Return on Equity: -0.5% Most Recent Quarterly Dividend: $0.11 Dividend Yield: 2.6% Please refer to important disclosures on […]
Sungrow Powers Ahead with New Solar and Storage Solutions at Intersolar South America 2025
SAO PAULO, Aug. 29, 2025 /PRNewswire/ — Sungrow, the global leading PV inverter and energy storage system provider, showcased its latest innovations in solar and storage technologies at Intersolar South America, held August 26-28, 2025. The company also announced a major milestone of 25 GW in cumulative contracted PV inverter orders and 10 GWh in energy storage systems […]
Toki AI Launches Groundbreaking AI Avatar Generator That Turns Any Photo into a Lifelike Avatar Video
SINGAPORE, Aug. 29, 2025 /PRNewswire/ — Toki AI has launched its breakthrough AI avatar generator, a revolutionary platform that transforms any single photo into lifelike, talking video avatars without requiring pre-training or additional footage. With this launch, Toki AI aims to overcome traditional challenges in avatar creation. The platform generates highly realistic AI talking avatars with […]
Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI ETM for the Treatment of Advanced Prostate Cancer
TAIPEI, Aug. 28, 2025 /PRNewswire/ — Foresee Pharmaceuticals (6576.TWO), (“Foresee”) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for CAMCEVI ETM (leuprolide mesylate 21 mg, ready-to-use long-acting injectable (LAI) formulation administered every 3 months), as a treatment for advanced prostate cancer. “The approval of CAMCEVI ETM […]
CamScanner Introduces “Turn Page to Auto Capture” Feature for Effortless Document Digitization
NEW YORK, Aug. 28, 2025 /PRNewswire/ — CamScanner, a leading mobile scanning application, today announced the launch of its new “Turn Page to Auto Capture” feature, an innovative tool designed to streamline the process of digitizing multi-page documents like books, contracts, and notebooks. This groundbreaking function is the first of its kind in the industry. […]
Friends of Science Society Challenges Investors for Paris Compliance Net Zero Complaint to Alberta Securities Commission
Friends of Science Society has issued an Open Letter to the Alberta Securities Commission responding to an Investors for Paris Compliance complaint about net zero reporting demands. The Net Zero Banking Alliance (NZBA) announced it is pausing activities. CALGARY, AB, Aug. 28, 2025 /PRNewswire/ — Friends of Science Society issued this Open Letter to the Alberta […]
Cognizant to Deploy 1,000 Context Engineers, Powered by ContextFabric™, to Industrialize Agentic AI
Cognizant and Workfabric AI join forces to create a new discipline that enables high-impact, enterprise-grade agentic AI solutions for clients across industries TEANECK, N.J., Aug. 29, 2025 /PRNewswire/ — Cognizant (NASDAQ: CTSH) today announced a strategic initiative to industrialize agentic AI across enterprises by deploying 1,000 context engineers over the next year. This move marks […]
Young Taiwanese Entrepreneurs Bring Fresh Vision to Fraser Residence Sudirman Jakarta
JAKARTA, Indonesia, Aug. 29, 2025 /PRNewswire/ — Fraser Residence Sudirman Jakarta marks a new chapter with the entry of its new shareholders—Mr. Michael Song and Mr. Thomas Song, visionary brothers and founders of Hung Kuang Pte. Ltd., a Singapore-based investment firm. With over a decade of experience in Taiwan’s real estate market, the Song brothers […]
LINE Investors Have Opportunity to Lead Lineage, Inc. Securities Lawsuit
NEW YORK, Aug. 28, 2025 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Lineage, Inc. (NASDAQ: LINE) pursuant and/or traceable to the registration statement issued in connection with Lineage’s July 2024 initial public offering (the “IPO”), of the important September 30, 2025 lead plaintiff deadline. […]